Company
United StatesPublic company, NYSE: CLColgate-Palmolive Company (NYSE: CL), Morristown, TN – FDA Inspections
Inspection records and compliance data for Colgate-Palmolive Company in Morristown, Tennessee. 5 FDA inspections on record, last inspected January 11, 2024. Publicly traded as NYSE: CL.
Company Profile
This profile covers Colgate-Palmolive Company based in Morristown, Tennessee, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected February 4, 2011. Last inspected January 11, 2024.
Most cited issue areas
- Adverse events--all info not in file1 inspection
- Calibration, Inspection, etc. Procedures Lack of or Inadequ1 inspection
- Investigation of device failures1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 11, 2024 | NAI | Human Drugs · Drug Quality Assurance | 1230984 |
| March 31, 2022 | NAI | Human Drugs · Drug Quality Assurance | 1167370 |
| July 15, 2021 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1146187 |
| April 20, 2016 | NAI | Human Drugs · Drug Quality Assurance | 973536 |
| February 4, 2011 | NAI | Human Drugs · Drug Quality Assurance | 709868 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Colgate-Palmolive Company
Stock ticker
CL
Exchange
NYSE
Share price
$97.91
Market cap
$77.8B
Price as of
November 13, 2026
FEI Number
3005874880
Address
200 Centennial Ct, Morristown, Tennessee 37813, United States
Country
United States
ID: 7db665f6-094f-4de5-bf3b-c2528e2a223b